Podrazil M, Taborska P, Stakheev D, Rataj M, Lastovicka J, Vlachova A, Pohunek P, Bartunkova J, Smrz D. Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy. Front Immunol 2022;13:892277. [DOI: 10.3389/fimmu.2022.892277][Cited by in Crossref: 1][Cited by in F6Publishing: 1][Article Influence: 1.0][Reference Citation Analysis]
Number
Citing Articles
1
Calzetta L, Chetta A, Aiello M, Frizzelli A, Ora J, Melis E, Facciolo F, Ippoliti L, Magrini A, Rogliani P. The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 2023;11:282. [DOI: 10.3390/vaccines11020282][Reference Citation Analysis]
2
Carr TF, Fajt ML, Kraft M, Phipatanakul W, Szefler SJ, Zeki AA, Peden DB, White SR; Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Research Group. Treating asthma in the time of COVID. J Allergy Clin Immunol 2022:S0091-6749(22)02454-X. [PMID: 36528110 DOI: 10.1016/j.jaci.2022.12.800][Reference Citation Analysis]